Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningitidis (MenC) wane after early infant immunization. METHODS: Children previously immunized in a randomized controlled trial at ages 2, 3, and 4 months with DTPa-IPV-Hib and MenC-CRM197 (MenC-CRM group...
প্রধান লেখক: | Khatami, A, Snape, MD, John, T, Westcar, S, Klinger, C, Rollinson, L, Boutriau, D, Mesaros, N, Wysocki, J, Galaj, A, Yu, L, Pollard, A |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
2011
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.
অনুযায়ী: Khatami, A, অন্যান্য
প্রকাশিত: (2012) -
Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
অনুযায়ী: Snape, MD, অন্যান্য
প্রকাশিত: (2009) -
Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
অনুযায়ী: Snape, MD, অন্যান্য
প্রকাশিত: (2006) -
Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
অনুযায়ী: Snape, M, অন্যান্য
প্রকাশিত: (2006) -
A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial
অনুযায়ী: Pace, D, অন্যান্য
প্রকাশিত: (2008)